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     SECTION I 
1. BACKGROUND AND SIGNIFICANCE 
 
The most common injuries to the permanent dentition are due to falls, traffic accidents, acts 
of violence and sports (Andreasen et al., 2000). Avulsion frequently occurs with injuries to 
the oral facial region and is the most serious of all dental injuries (Flores et al., 2007b). 
Treatment of these injuries is of the utmost importance and guidelines for the management 
of traumatic dental injuries have recently been published (Flores et al., 2007a, 2007b). Even 
with these guidelines and appropriate treatment of avulsed permanent teeth, the outcomes of 
replantation are not predictable (Strobl et al., 2003). It is often only considered a temporary 
solution (Ebeleseder et al., 1998). We have known for over 40 years that the avulsed 
immature tooth has potential to revascularize (Ohman, 1965). A treatment that encourages 
revascularization would be beneficial because in an immature tooth root development and 
reinforcement of root dentin walls by deposition of hard tissue will continue (Andreasen et 
al., 1995b). This decreases the chance of tooth fracture and avoids endodontic treatment 
which will ultimately weaken the tooth.   
Pulpal revascularization of the replanted tooth involves anastomosis of severed pulpal and 
boney socket blood vessels. Angiogenesis, the process of formation of new blood vessels 
from pre-existing capillaries governs the revascularization of these teeth. It has been known 
for more than a century that tumor growth is accompanied by increased vascularity (Ferrara, 
2004). Over sixty years ago it was proposed that a diffusible angiogenic growth “factor X” 
was responsible for neovascularization in the retina that occurs in diabetic retinopathy 
(Michaelson, 1948). Thirty years ago Folkman first proposed that angiogenesis was 
important for tumor growth and development (Folkman, 1971; Folkman and Shing, 1992; 
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Sivakumar et al., 2004). They discovered that the “switch” from avascular to the vascular 
phenotype was the key event in the progression of metastatic tumors (Hanahan and 
Folkman, 1996).  
It is now known that VEGF is a key player in angiogenesis and approximately three years 
ago, clinical trials were conducted which involved direct intramyocardial plasmid VEGF165 
gene therapy in patients with stable severe angina pectoris (Kastrup et al., 2005). VEGF165 
gene transfer did not significantly improve myocardial perfusion but it improved regional 
ventricular wall motion (Kastrup et al., 2005). The results were promising and VEGF165 
gene therapy is thought to have an important future role to play in the treatment of 
myocardial disease.   
Recently a tooth-slice based in vivo model system for the study of revascularization of 
severed human dental pulp was developed. It was shown that rhVEGF165 induced 
angiogenesis in dental pulps of human tooth slices in vitro (Gonçalves et al., 2007). With 
this model it is now possible to study revascularization events in severed human dental pulp. 
We also have the opportunity to study the effects of rhVEGF165 on severed human dental 
pulps in vivo. Our present study may have implications on the treatment of avulsed immature 
teeth prior to replantation.  
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2. PURPOSE AND HYPOTHESIS 
Purpose 
To evaluate the effect of rhVEGF165 and rhFGF-2 on the microvessel density of severed 
human dental pulps in vitro and to evaluate the angiogenic effect of the application of 
rhVEGF165 on severed human dental pulps in vivo. 
 
Hypothesis 
A pro-angiogenic factor (rhVEGF165) induces revascularization and angiogenesis of severed 
human dental pulps implanted in the subcutaneous tissue of immunodeficient mice.  
 
Specific aims 
Specific Aim 1: To assess the effect of the pro-angiogenic factors rhVEGF165 and rhFGF-2 
on the microvessel density of severed human dental pulp tissues in vitro. 
Specific Aim 2: To evaluate the effect of the protocol that provided the most potent 
angiogenic response (from Specific Aim 1) on severed human dental pulp tissue in vivo. 
 
Null Hypothesis 
A pro-angiogenic factor (rhVEGF165) does not induce revascularization and angiogenesis of 
severed human dental pulps implanted in the subcutaneous tissue of immunodeficient mice.  
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3. LITERATURE REVIEW 
A. Replantation and Revascularization of Avulsed Immature Permanent Teeth 
Dental injuries to permanent maxillary incisors are frequently found after orofacial trauma 
and treatment outcome is determined by the severity of damage to the periodontal ligament 
and neurovascular supply (Andreasen et al., 1995a, 1995b, 1995c, 1995d). Tooth avulsion is 
a complex type of trauma and involves damage to several vital structures (Andreasen et al., 
2006). Replantation is the treatment of choice, but complications occur; ankylosis, pulpal 
necrosis, pulpal obliteration, external root resorption and loss of boney support (Andreasen 
et al., 1995a, 1995b). Outcomes of replantation may vary and may not be predictable from 
the appearance or extent of injury sustained clinically (Strobl et al., 2003). Due to 
unpredictable treatment outcomes, replantation is often considered a temporary solution 
(Ebeleseder et al., 1998). For the clinician it is difficult to determine whether replantation 
will have a satisfactory long-term result, because many factors remain unknown at the time 
of replantation. Therefore replantation is recommended in nearly all cases. 
Factors that determine pulpal healing of avulsed teeth are the stage of root development at 
the time of injury and the time period between trauma and replantation (Andreasen et al., 
1995b). The most successful outcome of replantation is pulpal healing, but if this is to occur, 
revascularization of the severed pulpal vasculature must occur (Strobl et al., 2003). This is 
difficult especially in cases of delayed replantation (Ebeleseder et al., 1998).  
In 1966, Andreasen showed that of 13 teeth, seven showed pulpal revascularization when 
their extra oral period was less than two hours. Revascularization was also observed in 13 of 
72 replanted teeth with incomplete root formation (Kling et al., 1986). There was also a 30-
 4
40% chance of revascularization seen in replanted immature teeth (Ebeleseder et al., 1998). 
If all teeth were replanted immediately, a periodontal ligament healing rate of 85-97% 
(according to root development) could be expected. In cases of incomplete root formation, 
pulpal revascularization could be expected in 41-93% (Cvek et al., 1990) of cases and is rare 
in mature replanted teeth of children and adolescents with closed apices. More frequent 
pulpal healing was seen with increased apical diameter which is associated with the 
importance of a large interface between the pulp and periodontium in order to facilitate the 
revascularization process. This, in conjunction with immediate transplantation, showed 
significantly more frequent pulpal healing than delayed replantation cases (Andreasen et al., 
1995b). Pulpal revascularization was more frequent in teeth with shorter distances from 
apical foramen to the pulp horns. The relationship between pulp survival and pulp length 
was found to be highly significant. Thus all teeth with shorter pulp (less than 17mm) showed 
more frequent pulpal revascularization (Andreasen et al., 1995b). Also wet storage media 
(saliva or saline) for more than 5 minutes decreased the chance of revascularization, but dry 
extra-alveolar storage decreased the chance of revascularization with increasing length of 
extra-alveolar dry storage. Dehydration of pulpal cells could be expected to occur to a more 
limited extent due to protection against drying by the root canal walls except at the apical 
foramen. The damaging effect of dry storage upon healing found by Andreasen might 
therefore be limited to the most peripheral part of the pulp in the apical foramen. This effect 
in theory could be related to problems in the initial phases of the revascularization process. 
Attempts have been made to increase the chances of revascularization in order to gain more 
favorable treatment outcomes. Soaking avulsed dog teeth extra orally for 5 minutes in 0.05 
mg/ml of doxycycline before replantation increased the frequency of revascularization from 
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33.4% to 60%. (Yanpiset and Trope, 2000). Topical treatment of avulsed immature dog teeth 
(extracted and replanted within 10 minutes) with minocycline microspheres (ArestinTM, 
OraPharma Inc.) for 5 minutes was seen to improve the chances of revascularization after 
replantation when compared to doxycycline and saline. 91% of the teeth treated with 
minocycline showed vital tissue in the canal space. Normal pulp tissue with normal 
odontoblast layers were noted post histological sectioning. Internal reactive dentin with 
connective tissue, osteoid with loose connective tissue was also observed (Ritter et al., 
2004). It appears from these studies that tetracycline activity had a positive effect on 
revascularization. Tetracycline’s activity is related to its broad spectrum of activity against 
gram positive and gram negative bacteria. They also affect MMPs, which are a family of 
collagenases. The activity of MMPs appears crucial in the destruction of the major structural 
tissue protein, collagen. Tetracyclines inhibit collagenase activity and osteoclast function 
(Golub et al., 1991). They bind to tooth tissue and can be slowly released in active forms 
(Baker et al., 1983). Tetracyclines also promote the binding of fibroblasts to connective 
tissue thus enhancing PDL regeneration. But perhaps a more plausible explanation for 
tetracyclines effects on avulsed dog teeth is that, the necrotic pulp stayed free of bacteria and 
it could thus act as a scaffold for the tissue revascularization of the pulp space (Ritter et al., 
2005). These studies confirmed the clinical benefit of doxycycline and minocycline to 
enhance the revascularization of replanted teeth, but one has to remember that these studies 
were not conducted on human teeth.  
Prior to tetracyclines being used to treat avulsed teeth, attempts were made to increase the 
surface area of pulp tissue exposed to the bone-PDL interface. It was thought that this may 
increase the chances of revascularization. Apicoectomies were performed prior to 
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replantation. Teeth were extracted and replanted within 10 minutes and 2 mm of the apices 
of monkey teeth were resected for the purpose of examining pulpal vascularization 
(Andreasen et al., 1985). These teeth were examined histologically eight weeks after 
replantation and analysis showed that there was less vital pulp tissue found in teeth with 
immature root formation. Apical resection resulted in infection of pulp tissue, the apical 
tissues were damaged to such an extent that revascularization was slowed or made 
impossible and also resulted in a gap between the bone blood supply and the pulp. Similar 
results were seen for mature teeth. It was concluded that resection of the apices prior to 
replantation should be contraindicated (Andreasen et al., 1985). Unpredictable results were 
also observed using human teeth (Bolton, 1974; Janson et al., 1978). 
Similar studies were conducted using dog teeth. Pulpal revascularization occurred in eight of 
nine apicoectomized teeth (extracted and replanted within 10 minutes) during a four month 
observation period (Skoglund, 1981a). Revascularization did not occur in the teeth which 
were replanted and autotransplanted with intact roots or mature roots. The revascularization 
capacity of the pulp in transplanted and autotransplanted teeth could be increased if an 
apicoectomy is carried out at the time of replantation (Skoglund, 1981a). Histological 
assessment was carried out on these eight revascularized teeth. It was observed that the pulp 
of mature non apicoectomized replanted teeth had necrosed. In the mature teeth that were 
apicoectomized the pulp had first necrosed and then underwent repair via cells from the 
apical bed. This resulted in the formation of connective tissue (scaring) in the pulp space and 
was later replaced by bone or cementum like hard tissue. This tissue would make endodontic 
treatment difficult at a later date. Survival of the original pulp tissue was not achieved 
(Skoglund, 1981b).  
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Further attempts to increase the chances of revascularization were made by adding 
nutritional canals to resected root tips of mature dog teeth. It was hoped that these canals, 
three in total with a diameter of 1 mm, would aid in revascularization. The preparation of 
these canals did not lead to more extensive revascularization of the pulp. Some of the vessels 
that were growing in from the apical area anastomized to vessels growing in from the 
nutritional canals, but no advantage was gained from the preparation of the canals 
(Skoglund, 1983).  
The results from studies involving dog teeth must be interpreted with caution. Dogs have a 
peculiar root anatomy, with an apical delta which differs from humans which have an apical 
constriction. Thus resecting the apex removes the delta and makes a more favourable 
environment for pulpal healing (Andreasen et al., 1985). 
Revascularization of avulsed immature teeth is possible, but it only occurs in a small 
percentage of cases. The achievement of revascularization is beneficial as the extent of root 
development is related to pulpal revascularization (Andreasen et al., 1995c) and 
neurovascular survival. The necrotic pulp is avoided, root development is continued 
resulting in increased tooth strength against root fracture due to continued odontogenesis 
(Banchs and Trope, 2004). An infection free pulp-space is maintained, inflammatory 
resorption is avoided (Strobl et al., 2003) and the expense and danger of a procedural 
iatrogenic error associated with endodontic treatment is circumvented (Mesaros and Trope, 
1997).   
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B. Pro-angiogenic Factors 
Angiogenesis is the process that results in the formation of new blood vessels that deliver 
oxygen and nutrients to cells and tissue (Sivakumar et al., 2004). Blood vessels may 
originate from two processes: vasculogenesis and angiogenesis. In vasculogenesis, 
endothelial cell differentiation occurs from mesodermal precursor cells (angioblasts), 
whereas, in angiogenesis, new vessels are formed from pre-existing ECs. Angiogenesis is an 
important part of many natural processes, embryonic development, ovulation wound repair 
and pathological processes, arthritis, diabetic retinopathy, and tumors growth. In many 
diseases, the body looses control of angiogenesis, resulting in an excessive blood vessel 
development, as observed in cancer (Folkman and Shing, 1992). Vasculogenesis occurs 
during embryonic development and leads to the formation of the primary vascular plexus. 
This is further developed, forming a more complex system and ramifies into larger and 
smaller vessels. New capillary vessels are then formed through angiogenesis by the division 
of the original vessels (Auerbach and Auerbach, 2001).  
Angiogenesis is the result of a net balance between the activities of positive and negative 
regulators, survival and death signals (Nör and Polverini, 1999); proangiogenic and 
antiangiogenic factors. It is also a complex process and is controlled by a variety of growth 
factors, cytokines, proteases and protease inhibitors released from activated monocytes as 
well as ECs, smooth muscle cells, and platelets. It involves EC migration and proliferation, 
ECM breakdown, which is needed to provide space for enlarging vessels, pericytes, 
chemotaxis of macrophages, smooth muscle cell proliferation, development of new vascular 
structures and new extra cellular matrix deposition (Folkman, 1995).  
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Angiogenesis occurs when there is an increase in tissue size or an increased need for oxygen 
in hypoxia (Sivakumar et al., 2004). Apoptosis or programmed cell death is crucial to the 
angiogenic process. It is now established that key regulators of angiogenesis function, at 
least in part, by modulating the survival of ECs during the process of vessel repair and 
angiogenesis. Apoptosis is a mechanism that regulates the reshaping of tissues and organs 
(Fig. 1). It insures the survival of cells with the best adaptation to the environment, and 
eliminates infected, damaged cells that may have the potential to become neoplastic and thus 
when newly formed vessels are no longer needed they undergo regression. Targeted 
apoptosis of ECs seems to have an important physiological role allowing for the 
communication between the newly formed vessels and their parent capillaries (Nör and 



































Growth factors are peptide molecules that transmit signals between cells functioning as 
stimulators and or inhibitors of growth as well as modulators of cell differentiation. They 
play a central role in controlling cell behavior and activity. They show a degree of 
specificity in terms of the cells they act upon, but some growth factors exert their effects on 
a number of cell types (Smith, 2003). 
Growth factors may act in endocrine, autocrine, paracrine modes and they act through their 
interaction with specific receptors on the cell surface (Smith, 2003). Binding to these 
receptors leads to a chain of intracellular signals, the result of which is transduction of the 
signal to the cell nucleus. It is through their effects on gene expression in the cell nucleus, 
mediated by transcription and other factors, that the growth factors influence cell behavior 
and activity. This transcriptional control of gene expression can have far-reaching effects 
both in terms of intra- and extra-cellular events and so growth factors can regulate genes 
controlling cell proliferation, cell differentiation, or the secretory products of the cell (Smith, 
2003). 
There are vast numbers of growth factors and the following are pro-angiogenic factors. The 
VEGF family includes VEGF-A (commonly called VEGF), VEGF–B, VEGF–C, VEGF–D, 
VEGF–E and PDGF (platelet derived growth factor). Other growth factors are EGF 
(epidermal growth factor), Angiopoietin-1 and Angiopoietin-2 (Ferrara, 2004), Hepatocyte 
Growth Factor, TGF (Transforming growth factor α and β) (Abo-Auda and Benza, 2003) 
(Table 1), FGF-2 and IL-8; these do not belong to the VEGF family. 
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 Table 1. Superfamilies and families of commonly recognized growth factors 
 
Superfamily Family Abbreviated name 
Transforming Growth factor β Transforming Growth factor β 





Platelet-derived growth factor Platelet-derived growth factors 
Vascular endothelial growth factors 




Epidermal growth factor Epidermal growth factors 
Transforming growth factor α 
EGF 
TGF-α 
Other large peptide growth factor 
families 
Fibroblast growth factors 
Insulin-like growth factors 
Nerve growth factor 





*TNF-α and TNF-β are usually classified as pro-inflammatory cytokines, but sometimes 
considered within growth factor Classifications. 
    (Adapted from Smith, 2003)  
 
 
 Table 2. Specificity of the VEGF Receptors to the Ligand and the biological effects. 
 


















Angiogenesis and inflammation 
 (Adapted from Grando-Mattuella et al., 2007b) 
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Vascular Endothelial Growth Factor 
VEGF, a 45-kd heparin-binding glycoprotein, induces the differentiation, proliferation, and 
migration of endothelial cells, as well as vascular permeability and cell survival. It is 
considered essential for the differentiation of the vascular system (Ferrara, 1996).  
VEGF-A and VEGF-B are primarily related to angiogenesis (Table 2). VEGF is transcribed 
from a single gene locus by alternate splicing and it is made of polypeptide subunits 
containing 121, 145, 165, 189 and 206 amino acids. VEGF165 is the most common isoform 
(Tischer et al., 1991). VEGF expression is mediated by hypoxia and VEGF driven 
angiogenesis is a central response to low oxygen tension and it involves transcription factors 
HIF-1 and HIF- 2 (hypoxia induced proteins).  
VEGF receptors are primarily expressed on the vascular endothelial cell surface (Fig. 2). 
They include the tyrosine-kinase (RTK) type and are present in three forms: the fms-like 
tyrosine-kinase–1 (Flt-1) or VEGFR-1; the fetal liver kinase–1 (Flk-1), kinase domain 
region (KDR) or VEGFR-2; and the fms-like tyrosine-kinase– 4 (Flt-4) or VEGFR-3 
(Pimenta et al., 2003). VEGFR-1 is found on smooth muscle cells (Ishida et al., 2001), 
Monocytes (Barleon et al., 1996), stem cells (Hattori et al., 2002) and bone marrow derived 
blood cells (Lyden et al., 2001). VEGFR-2 is found on EPCs. There is strong evidence that 
the three receptors for VEGF possess different signal transduction properties and mediate 
different functions because of their distinct affinity to VEGF (Keyt et al., 1996).  Neuropilin 
is a type 1 membrane receptor, acts as a coreceptor that binds both VEGF-A165 and VEGF-
BB167.  Neuropilin 1 may also potentiate the effects of VEGF-B in cells where VEGFR-1 is 
expressed (Makinen et al., 1999). 
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VEGF is a survival factor for endothelial cells and prevents apoptosis (Alon et al., 1995) by 
inducing antiapoptotic proteins Bcl-2 (Gerber et al., 1998; Nör and Polverini, 1999), by 
activation of the PI3k/Alt pathway. This mediates a potent pro-survival effect on ECs 
(Gerber et al., 1998). VEGF is required for maintaining ECs survival and to sustain tumor 
angiogenesis. When a positive survival signal is eliminated, ECs become responsive to 
inhibitors of angiogenesis leading to EC apoptosis and tumor regression. The events that 
govern the survival and death of ECs influence the stability and duration of an angiogenic 







Figure 2. Binding of the VEGF Family Members to three High-Affinity Receptors on 
Endothelium and Downstream Signaling Cascades. 
(Yla-Herttuala et al., 2007). 
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Asahara et al. (1999) suggested that adult bone marrow is a reservoir of tissue specific stem 
and progenitor cells which contain EPCs that may be mobilized into the bloodstream and 
take part in neoangiogenesis. Depending on different diseases or events, molecules such as 
VEGF and PlGF have important roles in mobilization and differentiation of EPCs at 
neovascularization sites. The exact mechanisms by which EPCs are recruited remain 
unknown. 
VEGF has the ability to promote growth of ECs derived from veins, arteries and lymphatics. 
VEGF also acts to increase vascular permeability and other hemodynamic effects. VEGF 
induces EC fenestration in vascular beds and induces vasodilation in a dose dependent 
fashion (Ferrara, 2004). VEGF released by monocytes and ECs act on the capillaries and in 
doing so VEGFR-1 and VEGFR-2 are upregulated on these cells. Their activation results in 
the generation of proteases such as plasmin and collagenase, which then dissolve the 
basement membrane (Dvorak et al., 1995). There is also upregulation of integrins at the tips 
of sprouting capillaries which enhances endothelial cell migration and receptor activation. 
This results in EC migration via VEGFR-1 (Dvorak et al., 1995) and EC proliferation via 
VEGFR-2 signaling (Plouet et al., 1997).  
VEGF has a role in pathological conditions. VEGFR-1 is expressed by cancer cells which 
include glioma, leukemia, prostate, pancreatic and breast cancer cells. VEGFR-2 is primarily 
expressed on ECs. The inhibitory effects of anti-VEGF receptor blocking agents are used to 
inhibit angiogenesis, but this research is at an early stage and more clinical research is 
needed to ascertain the potential for these agents. Chemotactic signals from tumor cells 
recruit stromal cells and other angiogenic factors. Willet et al 2004 showed that VEGF 
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blockade using anti-VEGF monoclonal antibody bevacizumab (Genentech) decreases tumor 
perfusion, vascular volume, microvascular density, interstitial fluid volume, and the number 
of viable circulating ECs and EPCs in colorectal cancer patients. Bevacizumab (Avastin) 
was FDA approved in 2004 and it is now used to treat several cancer types including 
metastatic colorectal cancer and lung cancer.  
Clinical trials have been conducted with direct percutaneous intramyocardial plasmid 
phVEGF-A165 injection in patients with severe coronary artery disease (Kastrup et al., 2005). 
It was hoped that this form of gene therapy would have effects on the myocardial 
vasculature but the results were inconclusive. The VEGF gene transfer did not significantly 
improve stress-induced myocardial perfusion abnormalities compared with placebo plasmid. 
However, improved regional ventricular wall motion, as assessed by ventriculography, may 
indicate a favorable anti-ischemic effect (Kastrup et al., 2005).  Direct injection of rhVEGF 
into intramycardial tissues would be ineffective as rhVEGF has a very short half life, of 
between three and six minutes in vivo (Li et al., 1995; George et al., 2000; Pantely and 
Porter, 2000). This timeframe plus cardiac perfusion would impact on the angiogenic effects 
of direct rhVEGF injection. A recent review discussing VEGFs applications in clinical 
medicine showed that promising pre-clinic results obtained in animal experiments with 
VEGF therapy have not yet been translated into clinical success. VEGFs have tremendous 
potential as vascular therapeutics and ongoing developments in gene delivery techniques are 
expected to lead to the generation of novel treatment for ischemic cardiovascular disease 
(Yla-Herttuala et al., 2007).  
Of all the factors studied VEGF appears to be one of the most potent inducers of 
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angiogenesis. Much research has been carried out on VEGF over the last two decades to the 
point that we now can see a future where VEGF in many of its forms may be used to treat 
human injuries.   
 
Placental Growth Factor 
PlGF, a member of the VEGF superfamily is highly expressed in placenta at all stages of 
human gestation and loss of PlGF impairs angiogenesis (Maglione et al., 1991). PlGF binds 
with VEGFR-1 but not VEGFR-2. Alternative splicing of human PlGF gene generates 4 
isoforms, PlGF-1, PlGF-2, PlGF -3, PlGF-4 (Takahashi and Shibuya, 2005).  
 
Basic Fibroblast Growth Factor 
Fibroblast growth factor-2 (previously known as bFGF), is a prototypic and extensively 
studied member of a large family (FGF-1 to 23) of heparin binding, mitogenic growth 
factors. FGFs show developmental, tissue, cell-specific regulation and they are potent 
mitogens for cells of mesodermal and neuroectodermal origin and are powerful angiogenic 
agents (Ornitz, 2000). FGF-2 also has roles in tissue regeneration, wound healing, and tumor 
progression (Gospodarowicz, 1990). FGF-2 is predominantly found in the normal 
myocardium and its expression is increased by hypoxia or hemodynamic stress and chronic 
ischemia (Schaffer and Nanny, 1996).  
FGF-2 actions are mediated by its two isoforms, with differing molecular weights. To date, 
the vast majority of cardiac medicine clinical trials have involved the lo-FGF-2 (low 
molecular weight) isoform. FGFs bind to plasma membrane tyrosine kinase receptors, called 
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FGFRs (Kardami, 2007). It is believed that lo-FGF-2 is localized in the extracellular space, 
the cytosol of cells and it translocates to the nucleus during the G1-S transition of the cell 
cycle (Bossard et al., 2003). During cell injury and repair FGF-2 is involved in repair, tissue 
regeneration (Detillieux et al., 2004). As this process requires angiogenesis, FGF-2 has a 
vital regenerative function in these events. FGF-2 functions by receptor binding (Ornitz, 
2000). Vessels generated by VEGF tend to be “capillary like and leaky” but those produced 
by FGF-2 appear to be more mature (Abo-Auda and Benza, 2003). FGF-2 affects smooth 
muscle cells, fibroblasts, and ECs (Slavin, 1995). The ECs are stimulated to produce 
plasminogen activators and matrix metalloproteinases causing extracellular breakdown and 
vascular remodeling. In animal studies, increased EC proliferation, increased collateral 
vessel density, higher perfusion pressure and improved regional blood flow have been noted, 











C. Angiogenic Growth factors and the Dental Pulp 
Growth factors which affect the pulp have two sources. Pulp cells express VEGF in healthy 
and pathological situations such as irreversible pulpitis (Artese et al., 2002). These cells 
include odontoblasts, fibroblasts, undifferentiated mesenchymal cells, macrophages (found 
in the inflamed pulp), lymphocytes (B and T), dendritic cells, Schwann cells, pericytes and 
endothelial cells. But the odontoblasts and undifferentiated pulp cells are the most important 
cellular sources of VEGF in the dental pulp (Telles et al., 2003). High levels of VEGF 
secreted by unstimulated pulp cells provide a pro-angiogenic input that appears to be 
necessary to maintain pulp vascularization (Botero et al., 2003).  
The other source of growth factors is the dentin matrix. The origin of these growth factors in 
dentin matrix is probably largely the odontoblast cell (Smith et al., 1990; Smith, 2003). 
Dentin Matrix contains a cocktail of biologically active molecules with a wide range of 
effects once released. Whilst dentin matrix is not generally considered to show appreciable 
turnover or remodeling, trauma to the tissue might lead to release of these molecules 
(Roberts-Clark and Smith, 2000) (Table 1). During the carious process, acids released from 
bacteria diffuse through the dental tissue. They dissolve enamel and dentin matrix causing 
the release of growth factors. These growth factors are contained in both the soluble and 
insoluble tissue compartments of the matrix. Their release may vary under different tissue 
conditions. The sequestration of growth factors within dentin matrix provides a pool of 
growth factors that can be mobilized in injury. Fibroblasts and other pulp cells may be other 
sources. Thus, the overall response in the pulp is likely to be the summation of the effects 
caused by the release of growth factors from the dentin matrix and local secretion from
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pulp cells (Smith et al., 1990). 
Growth factors released from dentin include VEGF (Roberts-Clark and Smith, 2000). FGF-2 
PlGF, PDGF-AB and EGF have been also been isolated in dentin (Roberts-Clark and Smith, 
2000). Once unconstrained by the dentinal matrix these growth factors may play a role in 
pulpal angiogenesis. These factors are involved in pulpal healing (Roberts-Clark and Smith, 
2000) and are free to bind to their receptive receptors. VEGFR-2 has been identified in 
young permanent teeth. This receptor, localized by immunohistochemistry, has a uniform 
distribution in dental pulp tissue (Grando Mattuella et al., 2007a).  Therefore the release of 
growth factors could account for the increased local angiogenesis seen at sites of dental 
tissue repair after carious or traumatic injury (Smith et al., 1990).  
FGF-2 is also a potent mitogen for human pulp cells and it inhibits the expression of the 
odontoblast phenotype by the cells at least partly at pre-transcriptional levels (Shiba, 1995). 
FGF-2 suppresses terminal differentiation and calcification in pulp cell cultures (Shiba, 
1995). FGF-2 receptors as well as VEGF receptors have been immunohistochemically 
localized in the dental pulp. Receptors were also localized in the developing dental pulp, in 
preameloblasts and the distal ends of differentiating ameloblasts (Cam et al., 1992; 
Tanikawa, 1999). Once a pulp has been traumatized complete healing requires not only 
reparative dentine production but also angiogenesis and nerve fiber growth. VEGF and FGF-
2 have been demonstrated in pulp fibroblasts by immunohistochemistry and their release 
increased shortly after injury, showing a very rapid response suggesting a role directly 
linked to injury. These growth factors exert their angiogenic effects as soluble factors. The 
release of these factors occurs quickly following injury. Odontoblast progenitor cell 
 22
migration to the injury site may require newly formed blood vessels. These can be initiated 
by the secretion of angiogenic growth factors by dental pulp fibroblasts (Tran-Hung et al., 
2006). 
Bacteria products that reach the dental pulp during the carious process or a result of trauma 
also have a role to play in stimulating pulpal angiogenesis. LPS (Endotoxin) from gram 
negative bacteria can induce VEGF in pulp cells (Matsushita et al., 1999). VEGF protein 
expression is upregulated in (mouse) odontoblast like cells and macrophages exposed to 
LPS, but not in undifferentiated pulp cells or fibroblasts. Odontoblasts and macrophages are 
thus the key players in pulpal neovascularization in teeth with deep carious lesions (Botero 
et al., 2003). 
LTA another bacterial product, from gram positive streptococci can induce up regulation in 
VEGF protein expression in macrophages, odontoblast cells and in undifferentiated pulp 
cells. LTA does not induce VEGF expression in fibroblasts. VEGF mRNA expression 
remains constant upon exposure to LTA, suggesting that VEGF upregulation in these cells is 
post-transcriptional. Therefore LTA from gram positive bacteria might have a direct role in 
the enhanced neovascularization observed in infected sites of pulp tissue (Telles et al., 
2003). 
The pulp, when irritated by caries or traumatic injury reacts by releasing pro-angiogenic 
factors. These are supplemented by factors released from carious demineralized dentin. The 
net result is angiogenesis with resultant regeneration, but only if the injury is minor. As the 
intensity of the injury increases with resultant infection of the pulp, the regenerative 
potential of these pro-angiogenic factors will ultimately be overwhelmed.  
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D. Tooth Slice Based Models for the Study of Human Dental Pulp Angiogenesis 
Originally, research using Tooth Slice Models was undertaken not to study pulpal 
angiogenesis and revascularization but rather to investigate in vitro tissue injury processes in 
the dentin-pulp complex (Magloire et al., 1996). Culture models of this nature were useful 
for testing factors regulating pulpal repair. In one of the first models, cavities were prepared 
occlusally in extracted caries free, non-restored third molars of 12-22 year old patients to 
simulate injury of the dentin-pulp complex. Longitudinal tooth slices (crown to apex) of 
dentin-pulp complex, 0.75 mm thick were cultured in vitro in Basal Medium Eagle 
supplemented with 50 μg/ml  ascorbic acid, 50 μg/ml streptomycin, 100 IU/ml penicillin and 
10% fetal calf serum. Under the injured zone at day 0, the cytoplasm of cells appeared to 
have coagulated and there were vacuoles beneath the dentin. The rest of the pulp remained 
unchanged. At 12 days under the injured dentin, elongated cells were seen aligned along the 
edge of the pre-dentin and at 16 days, this was more evident. Tissue recovery was observed 
at the periphery of the pulp. Neovascularization was evident as packed thin vessels parallel 
to the dentin walls or subjacent to the cell layer underlying the prepared cavities. Sound 
polarized odontoblasts were observed in cultures maintained for 21 days under healthy non-
injured dentin. Long-term maintenance of the odontoblast phenotype was correlated with the 
presence of dentin matrix components released during demineralization caused by the 
ascorbic acid in the culture medium. This study demonstrated that severed dentin-pulp 
complex from human teeth could be cultured in vitro (Magliore et al., 1996).  
Tooth slice models involving rat teeth have also been used to study tissue injury and repair 
processes in the dentine-pulp complex over long periods of time (Sloan et al., 1998). 2 mm 
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thick slices were cultured for 14 days in DMEM supplemented with 0.15 mg/ml ascorbic 
acid, 10% heat inactivated fetal calf serum, 200 mM L-glutamine, 1% 
penicillin/streptomycin and 1% low melting agar. After 2 days of culture, it was noted that 
cell and tissue morphology was preserved throughout the dentine-pulp complex. 
Odontoblasts were visible as tall, columnar cells with polarized basal nuclei. They were in 
contact with the pre-dentin and the dentine extracellular matrix. Fibroblasts of the central 
core of the pulp were spindle-shaped and of similar density to those of the uncultured 
tissues. The morphological appearance resembled that of uncultured tissues. After 5 days, 
odontoblasts had maintained their phenotypic morphology and were in contact with the 
dentin extracellular matrix. Normal tissue morphology was still evident in cultures of 7 days. 
At 14 days the polarity and the morphology of the odontoblasts and the integrity of the 
dentine pulp complex was well maintained. However, after 14 days the odontoblasts began 
to show some ultrastructural changes. There was a reduction in the length of the cell bodies. 
Their columnar appearance became less distinct. This model maintained the vitality of the 
dentin pulp complex up to 14 days. It was demonstrated that this model could be used to 
study cell-matrix interactions in mature dental tissues and regulatory processes controlling 
cell activity in the dentine-pulp complex. This was the first indication that angiogenesis 
could possibly be studied in severed dental pulps, but only up to 14 days in vitro (Sloan et 
al., 1998). 
Further studies cultured 2 mm thick; rat incisor tooth slices for 10 days (Murray et al., 2000) 
or 21 days (Saw et al., 2005). These pulp-dentin complexes were cultured in vitro with a 
view to analyzing the effect of dental materials on the pulp. These involved either direct or 
indirect contact of the materials with the dentin-pulp complex (Saw et al., 2005). 
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Throughout the culture period, no morphological alterations were seen in dentin-pulp 
complex. The pulp tissue, contained in the tooth slices remained viable over a 10 day 
experimental period (Murray et al., 2000). There were no changes in the cell densities of 
odontoblasts and fibroblasts in the central pulp core after 7 days in culture, but after 14 days, 
pulpal cells within the tooth slice could not maintain their cell densities and normal 
morphological changes. Odontoblasts appeared shrunken with loss of cellular details and 
fewer pulp fibroblasts were identified.  There was a dramatic decrease of viable cells after 
21 days in culture (Saw et al., 2005).  From these models, it appears that between 7 and 14 
day in vitro culture is viable but 7 days is optimal.  
Recently it was shown that VEGF is capable of inducing an angiogenic response in dental 
pulps in vitro (Gonçalves et al., 2007). A tooth-slice based in vivo model system was 
developed to study the effect of VEGF on angiogenesis and revascularization events in 
severed human dental pulp. It was shown that this might become a useful model for studies 
of novel therapeutic strategies for the treatment of avulsed teeth (Gonçalves et al., 2007). 
The Tooth Slice Based Model utilized was based on Anthony Smith’s original in vitro 
approach for the study of dentinogenesis by organ culture of the dentin-pulp complex from 
rat incisor teeth (Sloan et al., 1998). Non-carious human third molars were sliced with a 
sterile diamond saw cross-sectionally at the CEJ to produce 1.5 mm thick slices. For the in 
vitro part of the study tooth slices were cultured in tooth slice culture media (High glucose 
DMEM supplemented with 20% heat inactivated fetal bovine serum (FBS), 5 ml L-
glutamine 200 mM, 5 ml of 10,000 units of penicillin and 10 mg/ml streptomycin, 1 ml 
Amphotericin B 1.25 mg/ml and 0.15 mg/ml vitamin C) supplemented with 50 ng/mL 
rhVEGF165. Tooth slices were cultured for seven days. The pulp tissues retained the overall 
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histological features of normal dental pulps, having intact odontoblast layers. Adding VEGF 
to the culture media resulted in an increase in microvessel density compared with untreated 
controls (Gonçalves et al., 2007).  
The in vivo protocol used in the study involved implanting tooth slices in the subcutaneous 
tissues of SCID mice for 7 days. The dental pulp tissue of all tooth slices implanted in the 
mice remained vital and an intact odontoblast layer was maintained in the tooth slices for the 
duration of the experiment (Gonçalves et al., 2007). The dental pulps were highly 
vascularized at the time of implant retrieval. The presence of functional (blood carrying) 
blood vessels in the dental pulps of the tooth slices implanted suggest that the existing blood 
vessels from the severed dental pulp were capable of anastomizing with host blood vessels. 
This might have been accomplished by hypoxia generated locally prior to implantation 
which stimulated the expression of VEGF, presumably through the activation of hypoxia 
inducible factor and initiated angiogenic cascades in the pulp tissue. Another possible 
mechanism is during the tooth slicing process growth factors including VEGF were released 
from the dentin matrix and directly stimulated angiogenesis and revascularization of the 
severed pulp tissue.   
Presently it is possible to study revascularization events in the dental pulp in vivo. The 
current model was achieved by advances in the characterization of in vitro tooth slice 
models. These were initially used to study the regenerative events of dental pulps in 
response to injury, the response of pulps to dental restorative materials and pulpal 





















     SECTION II 
1.  ABSTRACT 
Tooth avulsion is a common type of trauma in children and young adults. Replantation is the 
treatment of choice. Complications such as ankylosis, pulpal necrosis, pulpal obliteration, 
external root resorption make the long-term prognosis of avulsed teeth unpredictable. 
Recently, it was shown that vascular endothelial growth factor (VEGF) is capable of inducing 
an angiogenic response in dental pulps in vitro. However, we do not know if this angiogenic 
factor induces revascularization of severed dental pulps in vivo. The purpose of this study was 
to evaluate the effect of VEGF on the revascularization of human pulp tissue of tooth slices 
implanted subcutaneously in severe combined immunodeficient (SCID) mice. Non-carious 
human third molars were sliced with a sterile diamond saw (Model 650, Southbay 
Technology) cross-sectionally at the CEJ to produce 1 mm thick slices. Slices were treated ex 
vivo in culture media (DMEM) supplemented with 50 ng/ml rhVEGF165 or in control culture 
medium. After 1 hour, tooth slices were implanted subcutaneously in SCID mice. After 14 
days, mice were euthanized, tooth slices retrieved, and dental pulp microvessel density was 
quantified by counting the number of Factor VIII positive blood vessels in four high powered 
fields per pulp slice (12 tooth slices per condition). Independent experiments were carried out 
to verify data reproducibility, and statistical analyses (Kruskal-Wallis One Way Analysis of 
Variance on Ranks and Tukey’s Test) were performed using Sigmastat 2.0 software. We 
observed that the human dental pulps of the tooth slices remained viable for 14 days 
subcutaneously in the SCID mice under this experimental protocol. Notably, pre-treatment 
with VEGF prior to implantation increased the dental pulp microvessel density (p<0.05) 
compared to untreated controls. We conclude that VEGF enhances neovascularization of 
severed human dental pulps in vivo. These results may have implications on the treatment of 
avulsed immature teeth ex vivo, prior to replantation. 
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2. INTRODUCTION 
Trauma to the oral region is frequent in children and adolescents. It comprises 5% of all 
injuries for which treatment is sought, and in preschool children these traumatic injuries can 
be as high as 18% of all injuries. Of all facial injuries, dental are the most common. 
Avulsions occur in 1–16% of all dental injuries (Andreasen et al., 2007). The avulsion of 
permanent teeth is the most serious of all dental injuries. The prognosis depends on measures 
taken at the place of accident or immediately after the avulsion. Replantation is the treatment 
of choice, but cannot always be carried out immediately (Flores et al., 2007b). If this can be 
achieved pulpal revascularization could be expected in 41-93% of cases (Andreasen et al., 
1995b). Revascularization is rare in mature replanted teeth of children and adolescents with 
closed apices (Cvek et al., 1990). If immediate replantation cannot be carrier out 
complications can occur. These include ankylosis, pulpal necrosis, pulpal obliteration, 
external root resorption (Andreasen et al., 1995a, 1995b). The most successful outcome of 
replantation is pulpal healing, but if this is to occur, revascularization of the severed pulpal 
vasculature must take place (Strobl et al., 2003). This is difficult especially in cases of 
delayed replantation (Ebeleseder et al., 1998).  
Angiogenesis is defined as the process of developing new blood vessels from pre-existing 
capillaries (Folkman and Shing, 1992). It is an important part of many natural processes, such 
as embryonic development and ovulation wound repair. It is also involved in pathological 
processes such as arthritis, diabetic retinopathy, and tumor growth. In many diseases the body 
looses control of angiogenesis resulting in excessive blood vessel development as observed in 
cancer (Folkman and Shing, 1992). Vascular Endothelial growth factor (VEGF) plays a 
central role in angiogenesis, promoting the formation of new capillaries. VEGF increases 
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vascular permeability (Dvorak et al., 1985; Dvorak et al., 1995). Basic Fibroblast Growth 
Factor (FGF-2) is another potent angiogenic factor that shows increased expression in 
hypoxic conditions (Kardami, 2007). FGF-2 causes increased endothelial cell proliferation 
and collateral vessel density (Baffour et al., 1992).  
VEGF has received much attention regarding its potential therapeutic use in therapeutic 
angiogenesis for the treatment of vascular conditions such as myocardial ischemia (Kastrup et 
al., 2005; Yla-Herttuala et al., 2007). Promising preclinical results obtained in animal 
experiments with VEGF therapy have not yet been translated into clinical success (Yla-
Herttuala et al., 2007). VEGF has tremendous potential in vascular therapeutics and with 
further developments in gene delivery techniques it may be possible to develop a novel 
treatment for ischemic cardiovascular disease (Yla-Herttuala et al., 2007). 
Recently, a tooth-slice based in vivo model system was developed and characterized for the 
study of revascularization in the dental pulp. It was shown that VEGF induced angiogenesis 
in the dental pulps of human tooth slices in vitro (Gonçalves et al., 2007). However, we do 
not know if VEGF induces revascularization of severed dental pulps in vivo. Using the Tooth 
Slice Based Model, we explored the application of angiogenic growth factor/s to severed 
human dental pulps both in vitro and in vivo, with the implantation of 1 mm thick tooth slices 
into the dorsal subcutaneous tissue of SCID mice for a two week period.  Here we present the 
results of these experiments. We believe that these results may have implications for the 
direction of future studies involving the treatment of avulsed immature teeth ex vivo, prior to 
replantation.  
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3. MATERIALS AND METHODS  
In vitro Culture of Severed Human Dental Pulps (Fig. 3) 
Vital, non-carious and non-restored human third molars from patients no older than 30 years 
of age were collected from the Oral Surgery Department of the University of Michigan 
School of Dentistry, Ann Arbor, Michigan. After extraction, the teeth were immediately 
placed into sterile Transport Medium i.e. high glucose DMEM (Sigma Chemical Co.) 
supplemented with L-glutamine (Gibco), penicillin, streptomycin (Gibco) and Amphotericin 
B (Sigma).  The teeth were surface disinfected using a sterile gauze swab soaked in 70% 
ethanol solution. Excess soft tissue covering the root surface was removed with a sterile 
curette.  Tissue surrounding the apices of the third molars was left intact.  
 
Preparation of Specimens 
Teeth were fixed to a wooden block (3 cm x 3 cm x 1.5 cm) by self curing acrylic (Coldpac, 
tooth acrylic, Moltoid, Chicago, IL) and these blocks were attached to an Isomet Low Speed 
(Model 650, South Bay Technology, Inc., San Clemente, CA) (Fig. 4) saw mount. The teeth 
were cut into sections of 1 mm thickness with a lapidary blade 303 Series (MK-303 
Professional, MK Diamond Products Inc., Calais, ME) and cooled with sterile PBS-1x-
phosphate buffered saline (Gibco). The saw was washed with 70% ethanol and sterile PBS.  
Two tooth slices were taken from each third molar. The first tooth slice was cut from the CEJ 
and the second was taken apically to the first tooth slice. Both slices contained pulp tissue 
from the pulp chamber. The slices were placed into individual wells of a 12 well plate (BD, 
Franklin Lakes, NJ). Each well contained enough Culture Media (1ml) (High glucose DMEM 
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supplemented with 20% heat inactivated fetal bovine serum (FBS) (Gibco), 5ml L-glutamine 
200mM, 5ml of 10,000 units of penicillin and 10 mg/ml streptomycin, 1ml Amphotericin B 
1.25 mg/ml and 0.15 mg/ml vitamin C (Sigma)) to cover the tooth slice. Sections were then 
cultured at 37 oC, in 5 % CO2 and air, in a humidified (100% H20) incubator for seven days. 
The tooth slice culture media was changed the day after sectioning the teeth and every second 




















Figure 3. Tooth Slice Model to Study Pulpal Revascularization (Adapted from  















Figure 4. Diamond Wheel Saw Model 650 (Southbay Technologies, San Clemente, 
California) with a third molar fixed to a wooden mounting block by acrylic resin, in the 
cutting jig.  The sectioning of the third molars was performed in a cell culture hood under 
aseptic conditions.  
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Experimental Design 
Group 1: four tooth slices cultured in tooth slice culture media (without growth factors; 
negative control). 
Group 2: four tooth slices cultured in tooth slice culture media supplemented with 10 ng/ml 
rhVEGF165  (R&D Systems Inc., Minneapolis, MN). 
Group 3: four tooth slices cultured in tooth slice culture media supplemented with 50 ng/ml 
rhVEGF165. 
Three independent experiments were performed, using this experimental design. Data was 
analyzed from 12 slices per experimental condition.  A further four independent experiments 
were also conducted, but the histological sections from all three groups contained areas of 
pulpal voiding and were unsuitable for microvessel quantification (Fig. 14; page 82 
APPENDIX). 
The same experimental design was employed for FGF-2, as an alternative pro-angiogenic 
factor to VEGF. Three independent experiments were performed. Data was analyzed from 12 
favorable slices per experimental condition. One independent experiment was also conducted, 
but the histological sections from all three groups contained areas of pulpal voiding and were 
unsuitable for microvessel quantification (Fig. 14; page 82 APPENDIX).  
 
Removal of Slices From Culture  
After seven days, tooth slices were removed from the media and fixed in 10% buffered 
formalin (Fisher Scientific, Pittsburg, PA) at 4oC for 24 hours, followed by demineralization 
in Decalcifier (Decalcifier II, Surgipath Medical Industries Inc., Richmond, IL) for 22 hours 
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at RT (APPENDIX). Tissues were processed at the Histology Core University of Michigan, 
School of Dentistry and embedded in paraffin for histological examination. Three sections of 
each tooth slice were cut at 5 µm thickness with a microtome and one section was stained 
with Hematoxylin and Eosin (Sigma Aldrich, St. Louis, MO), two were processed for Factor 
VIII immunostaining as described (APPENDIX).  
 
In vivo Culture of Severed Human Dental Pulps 
Vital, non-carious and non-restored human third molars from patients not older than 30 years 
of age were collected from the Oral Surgery Department of the University of Michigan 
School of Dentistry, Ann Arbor, Michigan. After extraction the teeth were placed 
immediately into sterile Transport Medium. The teeth were handled and sliced as in the in 
vitro experiment (as described previously).  
After cutting, the slices were placed into individual wells of a 12 well plate (BD, Franklin 
Lakes, NJ). Each well contained enough culture medium to cover the tooth slice. The slices 
were placed into wells which correspond to the correct control and experimental groups.  
Group 2 tooth slices had the pulpal tissue removed (APPENDIX) prior to placement in the 
culture media. Group 4 the tooth slices were placed into culture media containing 50 ng/ml 
rhVEGF165.  The tooth slices were cultured ex-vivo at 37 oC, in 5% CO2 and air, in a 
humidified incubator for 1 hour prior to implantation.  
SCID mice (CB.17 SCID; Charles River, Wilmington, MA) were anesthetized with a solution 
of ketamine/xylazine. The use and handling of animals in this study was performed in 
accordance with an approved IRB and UCUCA protocols (APPENDIX). Each SCID mouse 
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received a 2 cm long incision in the dorsum with a #15 blade scalpel. Bilateral subcutaneous 
pockets were made upon separation of the dermis from the underlying muscle layer and one 
tooth slice was placed in each pocket, within 3 hours of extraction. Two tooth slices were 
implanted into each mouse; a control slice on one side and an experimental slice on the other. 
The tooth slices were placed in contact with the exposed muscle fibers. The dorsal incision 
was re-approximated to obtain wound closure using Vetbond Tissue Adhesive (3M Animal 
Care Products, St Paul, MN). The mice were examined two hours after the surgery for signs 
of recovery and then every day thereafter for signs of infection at the wound site or other 




Group 1: Six slices cultured ex-vivo for one hour and immediately fixed in 10% Buffered 
Formalin (Fischer Scientific, Pittsburg, PA) after tooth cross-sectional slicing.  
Group 2: Six slices implanted for 14 days with no pulpal tissue.   
Group 3: Six slices implanted for 14 days. Tooth slices cultured for one hour ex vivo with no 
pro-angiogenic factor added to the tooth slice culture media.  
Group 4: Six slices implanted for 14 days. Tooth slices cultured ex-vivo for one hour in 
culture media supplemented with 50 ng/ml rhVEGF165.  





Retrieval of the Tooth Slices from the SCID Mice  
14 days after implantation mice were euthanized and the slices were removed (Fig. 5; Fig.6). 
The tooth slices were fixed in 10% buffered formalin (Fisher Scientific) at 4 oC for 36 hours, 
followed by demineralization in Decalcifier (Decalcifier II, Surgipath Medical Industries Inc., 
Richmond, IL) for 22 hours at RT, which were then processed  and embedded in paraffin for 
histological examination (Histology Core University of Michigan, School of Dentistry). 
Three sections of the tooth slice were cut at 5 µm with a microtome and one section was 




Figure 5. Retrieval of tooth slices from the SCID mouse, 




Figure 6. Implants after two weeks. (A) Tooth slice implanted with no pulp tissue. Notice the 
white bands of mouse connective tissue which invaded the pulp space. (B) Tooth slice with 
severed human dental pulp cultured for one hour ex vivo in tooth slice culture media. (C) 
Tooth slice with severed human dental pulp cultured for one hour ex vivo in tooth slice 




Factor VIII Immunohistochemistry was performed on each tooth slice to quantify blood 
vessel number per high powered field. Factor VIII Immunohistochemical analysis was 
performed using Dako CytomationEnVision + System-HRP (AEC) with rabbit primary 
antibodies. Histological sections were incubated with 1:250 polyclonal rabbit anti-human 
Factor VIII (Neomarkers, Fremont, CA) over night at 4 oC. Sections were washed with Wash 
Buffer (Dako), and incubated with second antibody (Labelled Polymer-HRP, anti-rabbit 
Dako) for 45 minutes at room temperature. Sections were washed with Dako Wash Buffer 
and AEC substrate chromogen (Dako) was applied for 2 minutes, the reaction was observed 
under a light microscope at 200x magnification. Sections were counterstained with 
hematoxylin. The slides were washed again with distilled water, dried and then a cover slip 
was placed over the histological section and fixed to the slide with aqueous mounting media 
(Vecta Mount AQ). Control histological sections were incubated over night at 4oC with 1:250 
polyclonal rabbit anti-human IgG (Fig. 8).  
 
Microvessel Quantification 
Quantitative analysis of blood vessel densities was performed by ascertaining the number of 
Factor VIII stained blood vessels in four 200X high powered fields, per tooth slice. A total of 
12 tooth slices were examined for each condition. 200x Images were acquired using Image 
Pro Plus (version 5.1.2.59 for Windows XP, Media Cybernetics Inc., Silver Spring, MD) 
software and a microscope (Eclipse E800, Nikon, Melville, NY). Four, 200x fields were 
chosen at random from each tooth slice, using a grid superimposed on a digital image, 
captured by a Digital Camera (RT Slider, Diagnostic Instruments Inc., Sterling Heights, MI) 
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(Fig. 7).  Each grid box was the same size as a 200x field captured by the camera. Fields were 
chosen that contained pulp only. If dentin was visible on the periphery of the pulp, then this 
field was not selected. If more than four fields were available for selection in a row of grid 
boxes in the center of the pulp, then four boxes were chosen at random (Fig. 7).   
 
Statistical Analysis 
Statistical analysis was performed using One Way ANOVA followed by Tukey’s Test for 
multiple group comparison and  Kruskal-Wallis One Way Analysis of Variance (for non 
normally distributed data) on Ranks with SIGMASTAT 2.0 statistical software (SPSS, 

















Figure 7. Grid superimposed on a 20x histological image using Image Pros Plus (version 
5.1.2.59 for Windows XP, Media Cybernetics Inc, Silver Spring, MD). Each grid rectangle is 
the same dimension as the 200X field image as visualized with the microscope (Nikon 
Eclipse E800, Melville, NY). 
 42
4. RESULTS 
In vitro Effect of VEGF and FGF-2 on Severed Human Dental Pulps   
We observed that after culturing the tooth slices in vitro for 7 days, the pulp tissues retained 
the histological features of normal pulps and remained viable under this experimental 
protocol (Fig. 8 A, B, C, E, F, G).  
In order to evaluate the effect of VEGF and FGF-2 on dental pulp angiogenesis, we cultured 
the tooth slices in the presence or absence of VEGF or FGF-2 and performed 
immunohistochemical staining to identify blood vessels (Fig. 8 F, G). Adding VEGF resulted 
in an increase in dental pulp microvessel density (p<0.05) compared to untreated controls 
(Fig. 8 I). FGF-2 treatment of tooth slices in vitro also increased the dental pulp microvessel 
density (p<0.05) compared to untreated controls (Fig. 8 I).  
 
In vivo Effect of VEGF on Severed Human Dental Pulps Implanted in the Subcutaneous 
Tissues of SCID Mice 
It has been shown that human blood vessels can be engineered by seeding primary human 
endothelial cells in scaffolds using the SCID Mouse Model of Human Angiogenesis (Nör et 
al., 2001). These experiments provided the basis for the implantation of tooth slices in the 
dorsal subcutaneous tissue of SCID mice. To evaluate the effect of VEGF on dental pulp 
angiogenesis in vivo, tooth slices were cultured in the presence or absence of VEGF for 1 
hour ex vivo prior to 14 day implantation. Immunohistochemical staining was performed to 
identify blood vessels (Fig. 9 D, E, F). Adding VEGF resulted in an increase in dental pulp 
microvessel density (p<0.05) compared to untreated controls (tooth slices not implanted but 
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cultured ex vivo for 1 hour, implanted with no pulp and untreated implanted pulp slices) (Fig. 
9 G). The pulp tissues retained the histological features of normal pulps (Fig. 9 A, B, C) 
under this experimental protocol and the severed human pulp tissue of all tooth slices 
implanted remained vital under the experimental protocol (Fig. 9 A-F). The dental pulps were 
highly vascularized at the time of implant retrieval. Red blood cells were visualized in the 
lumen of blood vessels stained with the Factor VIII Antibody (Fig. 9 F). This demonstrates 
that the severed human vasculature had anastomized with the SCID mouse vasculature and 



















Figure 8. Effect of VEGF on in vitro angiogenesis in severed human dental pulp. (A, D, E, H) Tooth 
slices were untreated or (B, F) cultured in presence of 50ng/ml of rhVEGF165 or (C, G) rhFGF-2. (A, B, 
 45
C) Hematoxylin/eosin staining of dental pulps after 7 days in culture (200x). (E, F, G) Microscopic 
fields of Factor VIII Immunohistochemistry for identification of blood vessels (red staining). (D, H) 
Negative control; primary rabbit anti-human Factor VIII antibody, substituted with rabbit anti-human 
IgG antibody. Notice no red stained microvessels (D, H). (I) Graph depicting the mean (±SD) number of 
Factor VIII positive blood vessels from 48 fields per condition. Asterisk indicates statistical significance 















Figure 9. Effect of VEGF on in vivo angiogenesis in human dental pulp. (A, D) Tooth slices 
implanted with no pulp tissue, (B, E) with untreated pulp tissue, (C, F) with pulp tissue treated with 
50ng/ml of rhVEGF165 for 1 hour ex-vivo prior to implantation. (A, B, C) Hematoxylin/eosin 
staining of dental pulps after 14 days implantation (200x). (D, E, F) Microscopic fields of Factor 
VIII Immunohistochemistry for identification of blood vessels (red staining). (G) Graph depicting 
the mean (±SD) number of Factor VIII positive blood vessels from 48 fields per condition. Asterisk 
indicates statistical significance (p<0.05). (Kruskal-Wallis One Way Analysis of Variance on Ranks 




This study builds on the principles that were developed and initially characterized in a SCID 
Mouse Model for the study of human angiogenesis (Nör et al., 2001; Gonçalves et al., 2007). 
This model was based on tooth slicing culture experiments, first described by Sloan and 
colleagues (Sloan et al., 1998). We demonstrated using a Tooth Slice Model (Fig. 10) that 
human dental pulps cultured for seven days in vitro retained their viability. We also 
demonstrated that human dental pulps of tooth slices remained viable for 14 days, 
subcutaneously in SCID mice under this experimental protocol. 
Pulp cells release growth factors in response to injury (Botero et al., 2006). VEGF is 
expressed by pulp cells (Telles et al., 2003) and is found in dentin matrix (Smith et al., 1990; 
Smith, 2003). It was shown that VEGF is upregulated in odontoblast-like cells that were 
exposed to bacterial endotoxins (Botero et al., 2006). FGF-2 released from human dental pulp 
following forced tooth movement plays a role in the angiogenic response of the pulp 
(Derringer et al., 2004). The quantity of VEGF and FGF-2 released from pulp cells exposed 
to bacterial endotoxins is unknown. This is currently under investigation in our laboratory.  
rhVEGF165 and rhFGF-2 are angiogenic in vitro (Nör et al., 2002). 50 ng/ml of rhVEGF165 
has prolongs the survival of human dermal microvascular endothelial cells in vitro (Nör and 
Polverini, 1999; Nör et al., 2002). Zero to 50 ng/ml of rhVEGF165 were used to examine pro-
angiogenic signaling pathways in human dermal microvascular endothelial cells in vitro (Karl 
et al., 2005). We used concentrations of 10 ng/ml and 50 ng/ml of rhVEGF165 and rhFGF-2 to 
treat severed human dental pulps in vitro. We observed that treatment of tooth slices with 50 
ng/ml of rhVEGF165 increased the dental pulp microvessel density (p<0.05) compared to 
untreated controls. We also observed that the in vitro treatment of tooth slices with 50 ng/ml 
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of rhFGF-2 increased the dental pulp microvessel density (p<0.05) compared to untreated 
controls. The exogenous rhVEGF165 or FGF-2 in the tooth slice culture media, plus the 
hypoxia induced VEGF in the severed pulp and also the VEGF and FGF-2 released from the 
dentin matrix during tooth slicing may have provided sufficient pro-angiogenic stimuli to 
enhance tissue microvessel density.  
Angiogenesis occurs at pre-existing capillaries (Folkman and Shing, 1992) and the 
subodontoblast layer contains a rich vascular network (Takahashi, 1985). Angiogenesis may 
have occurred in this region to a greater extent compared to the remainder of the pulp. We did 
not quantify microvessels in the subodontoblast layer. This is a limitation of our study. 
We cultured severed human dental pulp tissue ex vivo in tooth slice culture media 
supplemented with rhVEGF165 prior to SCID mouse implantation because recent clinical 
trials involving direct intramyocardial plasmid VEGF165 gene therapy in patients with angina 
pectoris were conducted (Kastrup et al., 2005). Results showed that gene therapy did not 
improve myocardial perfusion but anti-ischemic effects were noted. These trials highlighted 
the potential that VEGF has to induce tissue revascularization. We treated severed human 
dental pulp tissues ex vivo with 50 ng/ml of rhVEGF165 due to our observation that 
rhVEGF165 treatment of tooth slices in vitro increased the dental pulp microvessel density 
(p<0.05) compared to untreated controls. We chose one hour ex vivo treatment based on the 
half-life of VEGF. VEGF has a half-life between three and six minutes in vivo (George et al., 
2000; Pantely and Porter, 2000) and approximately one hour in vitro (Shi et al., 2001; Liu et 
al., 2002).  
We used Factor VIII immunohistochemistry to indentify microvessels in severed human 
dental pulps. Factor VIII immunohistochemistry is widely used in cancer research to identify 
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vascular “hot spots” in tumors (Uzzan et al., 2004; Des Guetz et al., 2006). We showed that 
the polyclonal rabbit anti-human Factor VIII antibody cross reacted with mouse vasculature 
(Fig. 9D). We obtained tooth slice histological sections which were cut through the severed 
human pulp tissue and not the mouse connective tissue attached to the exterior surface of the 
tooth slice. This avoided quantification of mouse vasculature, which would cause erroneous 
microvessel density analysis of the severed human dental pulps.  
Microvessel density analysis is frequently conducted in cancer research and performed by 
acquiring digital images from 200x high-powered fields of histologically processed tumor 
tissue (Kim et al., 2005; Saravanamuthu et al., 2003; Urquidi et al., 2002). We acquired 200x 
high-powered images from each severed human pulp (Gonçalves et al., 2007). Image Pro 
Plus, image analysis software has also been used in microvessel density analysis (Luo et al., 
2001; Fukasawa and Korc, 2004). We conducted microvessel density analysis using Image 
Pro Plus and we superimposed a grid (Hochberg et al., 2002; Inan et al., 2003; Kehrl et al., 
2004; Trojan et al., 2004) onto digital images of each pulp. Microvessels with and without 
lumens (Weidner, 1995) were counted from chosen fields, using the manual tagging function 
in the Image Pro Plus software. We chose four random fields from each pulp based on the 
results of a pilot study, which involved the application of a grid to a random sample of 60, 
20x digital images of tooth slices. We determined that four was the minimum number of 
fields which could be captured per tooth slice, upon grid application.  
We observed that the odontoblast layer was maintained in the tooth slices throughout the 
duration of the experiment and this correlated with the presence of dentin and dentin matrix 
components (Heywood and Apppleton, 1984; Begue-Kirn, 1992; Sloan et al., 1998). 
Histologically there was evidence of revascularization of the severed human dental pulps 
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implanted in the subcutaneous tissue of SCID mice. An intact, highly vascularized 
odontoblast layer was observed (Fig. 9 B, C).  The presence of functional blood vessels both 
in the VEGF treated and untreated tooth slices suggests that mouse blood vessels anastomized 
with the severed human dental pulp vessels (Fig. 6). This finding agrees with a recent study 
from our laboratory (Gonçalves et al., 2007). The dental pulp in response to hypoxia may 
have produced local VEGF, which encouraged revascularization of the dental pulp. 
Alternatively, growth factors may have been released from the dentin matrix during tooth 
slicing, triggering local pulpal angiogenesis which influenced the anastomosis of the mouse 
and human microvessels.  
The exogenous rhVEGF165 in the tooth slice culture media may have provided sufficient pro-
angiogenic stimuli to enhance tissue microvessel density, together with the hypoxia induced 
VEGF and the VEGF released from the dentin matrix. These events would ultimately result 
in pro-angiogenic effects, in the severed human dental pulps. We observed that rhVEGF165 
treatment of tooth slices ex vivo prior to implantation in SCID mice increased the dental pulp 
microvessel density (p<0.05) compared to untreated controls. 
Our results suggest that rhVEGF165 could be used to treat dental pulp conditions that require 
revascularization. This would include the avulsed immature tooth. At present pulpal 
revascularization can be expected in 41-93% of cases if replantation is immediate (Andreasen 
et al., 1995b). Immediate replantation is not always possible. We may in the future be able to 
increase the chances of revascularization and allow the replanted tooth to have the prospect of 
becoming more than a space maintainer and a short term solution. Slow release delivery of 
rhVEGF165 in a bioabsorbable polymer would allow application of the angiogenic factor 
directly to the pulp tissue at the apex of an avulsed immature tooth. A slow release method of 
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minocycline delivery in the form of ArestinTM microspheres (Ritter et al., 2004) could also be 
applied ex vivo in combination with rhVEGF165. This would provide both an antimicrobial 
and pro-angiogenic effect on the severed human pulp tissue. This method of delivering a 
combination of rhVEGF165 and minocycline is currently not available and warrants further 
investigation.  This is truly an interesting prospect but one must remember that this research 










































Figure 10. Tooth Slice Model to Study Revascularization of Severed Human Dental Pulp. 
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6. CONCLUSIONS 
The following are the conclusions from our work: 
 
1. rhVEGF165 induced angiogenesis in severed human dental pulps of tooth slices treated 
ex vivo prior to implantation in SCID mice. rhVEGF165 treatment increased the dental 
pulp microvessel density (p<0.05) compared to untreated controls. Human dental 
pulps remained viable for 14 days, subcutaneously in the SCID mice under this 
experimental protocol.  
 
2. We also observed that tooth slices cultured for 7 days remained viable. rhVEGF165 
and rhFGF-2 treatment induced an angiogenic response in dental pulps of tooth slices 
in vitro and increased the dental pulp microvessel density (p<0.05) compared to 
untreated controls.  
 
3. Results from this study may have implications for the direction of future studies on 
the treatment of avulsed immature teeth ex vivo, prior to replantation. They may also 
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1. In vitro Pilot Study. Three and Seven Day Culture of Severed Human Dental 
Pulps.  
A. Materials and Methods 
Part I: Tooth Slice Culture Media not supplemented with rhVEGF165  
Vital, non-carious and non-restored human third molars from patients not older than 30 years 
of age were collected from the Oral Surgery Department of the University of Michigan 
School of Dentistry, Ann Arbor, Michigan. After extraction the teeth were immediately 
placed into sterile Transport Medium (High glucose DMEM (Sigma Chemical Co.) 
supplemented with 5 ml L-glutamine (Gibco) 200 mM, 5 ml of 10,000 units of penicillin and 
10 mg/ml streptomycin (Gibco) and 1ml Amphotericin B (Sigma) 1.25 mg/l). 
The teeth were surface disinfected using a sterile gauze swab soaked in 70% ethanol solution. 
Excess soft tissue covering the root surface was removed by trimming with a sterile curette.  
Tissue surrounding the apices of the third molars was left intact.  
 
Preparation of specimens 
Teeth were fixed to a wooden block (3 cm x 3 cm x 1.5 cm) by self curing acrylic (Coldpac, 
tooth acrylic, Moltoid, Chicago, IL ref 44100) and these blocks were attached to an Isomet 
Low Speed (Model 650, South Bay Technology, Inc.) saw mount. The teeth were cut into 
sections of 1 mm thickness with a lapidary blade 303 Series (Mk-303 Professional, Mk 
Diamond Products Inc.) cooled with sterile PBS-1x-phosphate buffered saline (Gibco ref. 
10010). The saw was washed with 70% ethanol and sterile PBS. After cutting the slices were 
placed into individual wells of a multi-well plate (12 well). Each contained enough Tooth 
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Slice Culture Media (1 ml) (High glucose DMEM supplemented with 20% heat inactivated 
fetal bovine serum (FBS) (Gibco), 5 ml L-glutamine 200 mM, 5 ml of 10,000 units of 
penicillin and 10 mg/ml streptomycin, 1 ml Amphotericin B 1.25 mg/ml and 0.15 mg/ml 
vitamin C (Sigma)) to cover the tooth slice.  
 
Organ culture of the dentin-pulp complex 
Tooth slices in group one were slices taken from the CEJ (Large Pulps) and those in group 
two were sliced from or close to the furcal area of the human third molars (Small Pulps). 
Small Pulps were cultured for three days, while the Large Pulps were cultured for three and 
seven days.  
Tooth slices were then cultured at 37oC, in an atmosphere of 5% CO2 and air, in a humidified 
(100% H20) incubator for three and seven days. The tooth slice culture media was changed 
the day after sectioning and every second day thereafter.  
Experimental Design 
Group 1: Five Large Pulps (tooth slices) placed in tooth slice culture media for seven days.  
Group 2: Five Small Pulps (tooth slices) placed in tooth slice culture media for seven days.  
Group 3: Five Large Pulps placed in tooth slice culture media for three days.  





Part II: Tooth Slice Culture Media supplemented with 50 ng/ml rhVEGF165  
Vital, non-carious and non-restored human third molars from patients not older than 30 years 
of age were collected from the Oral Surgery Department of the University of Michigan 
School of Dentistry, Ann Arbor, Michigan and were placed in Transport Media immediately 
after extraction. The remainder of the protocol is similar to Part I, apart from differences in 
the experimental design.  
 
Experimental Design 
Group 1: Five tooth slices placed in tooth slice culture media for three days. 
Group 2: Five tooth slices placed in tooth slice culture media, supplemented with 50 ng/ml 
of rhVEGF165 and cultured for three days. 
Group 3: Five tooth slices placed in tooth slice culture media for seven days.  
Group 4: Five tooth slices placed in tooth slice culture media, supplemented with 50 ng/ml of 
rhVEGF165 and cultured for seven days.   
One independent experiment was conducted.  
 
Removal of slices from Culture  
After three or seven days the tooth slices were removed from the culture media and fixed in 
10% neutral-buffered formalin (Fisher Scientific ref. SF100-4) at 4oC for 24 hours, followed 
by demineralization in Decalcifier (Decalcifier II, Surgipath, ref 00460) for 22 hours at room 
temperature, which were then processed (Histology Core University of Michigan, School of 
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Dentistry) and embedded in paraffin wax for histological examination. Three sections of each 
tooth slice were cut at 5µm thickness with a microtome. One section was stained with 




After retrieval of tooth slices from the culture media after three or seven days and subsequent 
histological processing, FVIII Immunohistochemistry was performed on each tooth slice to 
quantify blood vessel number per high powered field. Factor VIII Immunohistochemical 
analysis was performed using Dako CytomationEnVision + System-HRP (AEC) with Rabbit 
Primary Antibodies. Histological sections were incubated with (Factor VIII related antigen 
Ab-1 Rabbit PAb ref. RB-281-A; antibody diluent- ref. S0809, 1:250 polyclonal rabbit anti-
human Factor VIII, over night at 4oC. Sections were washed with Wash Buffer (Dako ref. 
S3006), and incubated with second antibody (Labelled Polymer-HRP, anti-rabbit Dako, ref. 
4008) for 45 min at room temperature. Sections were washed with Dako Wash Buffer and 
AEC substrate chromogen (Dako ref. K4008) was applied for 2 minutes, the reaction was 
observed under a light microscope at 200x magnification. Sections were counterstained with 
hematoxylin, after retarding the chromogenic reaction by placing the histological slides in 
distilled water. The slides were washed again with distilled water, dried and then a cover slide 
was placed over the histological section and fixed to the slide with aqueous mounting media 
(Vecta Mount AQ ref H-5501). Slides were processed which contained histological sections 
from tooth slices that were fixed immediately post tooth slicing. The histological sections 
were incubated over night at 4oC with 1:250 polyclonal rabbit anti-human IgG (polyclonal 
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rabbit anti-human) substituted for Factor VIII related antigen Ab-1 Rabbit PAb as a negative 
control (Fig. 8). 
 
Microvessel Quantification 
Quantitative analysis of the blood vessel densities was performed on pulp tissue that was 
stained with Rabbit Primary Antibodies, by ascertaining the number of Factor VIII stained 
blood vessels per 200x high powered field, per tooth slice. Three 200x fields were chosen at 
random, using a microscope (Axioskop, Zeiss, Germany). One field was chosen in the center 
of the pulp and the other two close to the odontoblast layer, being careful to exclude dentin 
from the field. 
 
Statistical Analysis 
Statistical analysis was performed using One Way ANOVA followed by Tukey’s Test for 
multiple group comparison and Kruskall-Wallis One Way Analysis of Variance on Ranks (for 
non normally distributed data spread) with Sigmastat 2.0 statistical software (SPSS, Chicago, 
IL). The level of significance was determined at P ≤ 0.05. 
 
Part III: Quantification of VEGF and FGF-2 contained in DMEM and 20% FBS 
(constituents of Tooth Slice Culture Media) by ELISA 
VEGF ELISA and FGF-2 ELISA were conducted to ascertain if there were significant 
amounts of VEGF and or FGF-2 in formulated Tooth Slice Culture Media prior to 
supplementation with rhVEGF165. (APPENDIX: 2B and 2C. Protocols for VEGF ELISA and 
FGF-2 ELISA).  
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B. Results 
In vitro Pilot Part I  
Small and Large tooth slices were prepared under sterile conditions and were cultured for 
either three or seven days. Following fixation, demineralization, histological processing and 
Factor VIII Immunohistochemistry, microvessel quantification was performed under this 
experimental protocol. Immunohistochemical staining successfully identified microvessels 
(Fig. 11 A-F). 
We observed that after culturing tooth slices in vitro for three and seven days the human 
dental pulps remained viable and the tissues retained the overall histological features of 
normal human dental pulps, with normal odontoblast layers (Fig. 11 A-F). We also noted that 
there was a dramatic reduction in pulpal voiding (Fig. 14) in the histologically processed 5 
μm thick sections. This was a problem we encountered in the first two non pilot rhVEGF165 
experiments, which were conducted prior to the first pilot study.  
This problem was solved by placing the tooth slices retrieved from the culture media, 
immediately into 10% Neutral Buffered Formalin, chilled at 4oC. This dramatically reduced 
pulpal shrinkage.  
Microvessel quantification revealed no significant difference between the groups (Fig. 11 G).  
 
In vitro Pilot Part II 
Small and Large tooth slices were prepared under sterile conditions and were cultured for 
either three or seven days. Groups two and four were cultured in tooth slice culture media 
supplemented with 50 ng/ml VEGF. Following fixation, demineralization, histological 
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processing and Factor VIII Immunohistochemistry, microvessel quantification was 
performed. Immunohistochemical staining successfully identified microvessels (Fig. 12 A-
H). 
We observed that after culturing tooth slices in vitro for three and seven days the human 
dental pulps remained viable and the tissues retained the overall histological features of 
normal human dental pulps (Fig. 12 A-H). We also noted that there was a dramatic reduction 
in pulpal voiding (Fig. 14) in the histologically processed 5 μm thick sections. This was a 
problem we encountered in the first two non pilot rhVEGF165 experiments, which were 
conducted prior to the first pilot study.  
This problem was solved by placing the tooth slices retrieved from the culture media, 
immediately into 10% Neutral Buffered Formalin, chilled at 4oC. This dramatically reduced 
pulpal shrinkage.  
Adding VEGF to tooth slices cultured for seven days resulted in an increase in 
microvessels/high powered field as compared to the untreated controls (p<0.05) (Fig. 12 I). 
We observed that VEGF promoted an angiogenic response in severed human dental pulps, 
which were cultured for seven days in vitro.  
 
In vitro Pilot Part III 
Trace amounts of VEGF and FGF-2 were found in DMEM and 20% FBS (constituent parts 
of Tooth Slice Culture Media), but these amounts were not significant and would not interfere 
with the rhVEGF165 or rhFGF-2, which supplemented the Tooth Slice Culture Media in the in 







igure 11. In vitro Pilot Study Part I. (A-F) Tooth slices (small and large) were untreated and 
cultured either for three or seven days. (A-D) Tooth slices cultured for seven days. (E, F) 
Tooth slices cultured for three days. (A, C, E) Representative microscopic fields of Factor 
VIII immunohistochemistry for the identification of blood vessels (red staining) (100x) and 
(B, D, F) (200x). (G) Graph depicts the mean (± SD) number of blood vessels from 15 fields 





















Figure 12. In vitro Pilot Study Part II. Effect of VEGF on in vitro angiogenesis in human 
dental pulps. (A-H) Tooth slices (small and large) were either untreated or treated and 
cultured either for three or seven days. (C, D, G, H) Tooth slices cultured for seven days. (A, 
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B, E, F) Tooth slices cultured for three days. (A, E, C, G) Tooth slices were untreated or (B, 
F, D, H) cultured in the presence of 50 ng/ml VEGF. A-D Representative microscopic fields 
of Factor VIII immunohistochemistry for the identification of blood vessels (100x) and E-H 
(200x). Note the statistically significant difference between the group treated with 50 ng/ml 













Figure 13. In vitro Pilot Part III. Quantification of VEGF and FGF-2 in DMEM and 20% FBS 
(constituents of Tooth Slice Culture Media) by ELISA. (A) Graph depicting the mean (±SD; 
not visible as it is a relatively small value) of the pg/ml (Thousands) of VEGF contained in 
Plain DMEM, DMEM+20% FBS, DMEM+20% FBS+10 ng/ml rhVEGF165 and 
DMEM+20% FBS+50 ng/ml rhVEGF165. (B) Graph depicting the mean (±SD; not visible as 
it is a relatively small value) of the pg/ml (Thousands) of FGF-2 contained in Plain DMEM, 




Figure 14. Pulpal voiding. FVIII Immunohistochemical staining of a representative pulp after 
seven days in vitro culture (20x). Pulpal voiding was encountered in the initial tooth slice 
culturing experiments. It occurred due to pulpal shrinkage upon fixation. Shrinkage created a 
concavity in the pulp tissue. Histological sectioning through a concave pulp created a void 
with pulp tissue remaining mostly beneath the pre-dentin layer, with several large voids 
located centrally.   
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2. Laboratory Protocols 
 
A. Immunohistochemical staining protocol for Factor VIII with EnVision™ Systems 
(DakoCytomation, Carpinteria, CA) 
 
1. Bake slides at 37oC for 30 minutes; then bake at 60oC for 30 minutes.  
2. Cool slides at RT for 20 minutes. 
3. Deparaffinize and rehydration 
a. Xylene 1 3mins 
b. Xylene 2 3mins 
c. Xylene 3 3mins 
d. 100% ETOH 2mins 
e. 100% ETOH 2mins 
f. 95% ETOH 2mins 
g. 95% ETOH 2mins 
h. 75% ETOH 5 dips 
i. DDW  1min 
4. Antigen Retrieval 
Immerse slides in 1x Target Retrieval Solution (ref. S1699 DakoCytomation, 
Carpinteria, CA): 9x DDW. Incubate slides at 90oC in a water bath for 30 mins. 
Allow slides to cool for 20 mins. 
Circle tissue on the slides with a PAP Pen. 
Wash slides with 1x wash buffer (ref. S3006 DakoCytomation, Carpinteria, CA).   
5. Endogenous peroxidase blocking 
Place Peroxidase Blocking reagent (ref. K4008 DakoCytomation, Carpinteria, CA) on 
bench to equilibrate at RT. 
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Cover tissue sections with Peroxidase Blocking reagent and incubate at RT for 5 mins. 
Rinse gently with wash buffer. 
6. Primary Antibody 
1:250 dilute Factor VIII (Factor VIII related antigen Ab-1 Rabbit PAb (polyclonal 
rabbit anti-human Factor VIII) ref. RB-281-A Lab Vision Corporation, Neomarkers, 
Fremont CA; Antibody Diluent  (ref. S0809 DakoCytomation, Carpinteria, CA).  
Add primary antibody to slides and incubate at 4oC overnight. 
Rinse gently with wash buffer and remove excess buffer. 
7. Peroxidase Labeled Polymer (ref. K4008 DakoCytomation, Carpinteria, CA) 
Add HRP labeled Polymer, rabbit (AEC+), to each slide. Incubate for 1 hour. 
Rinse gently with wash buffer and remove the excess buffer. 
8. Chromogen development 
Add AEC+ solution (ref. K4008 DakoCytomation, Carpinteria, CA) to each slide. 
Incubate at RT for 3 mins (time dependent on background stain development). 
Stop reaction by placing the slides in DDW for 5 mins. 
9. Counter stain with Hematoxylin 
Place slides in Mayers Hematoxylin (Sigma Aldrich, St Louis, Missouri, MO). 
Rinse under running water to remove excess Hematoxylin. 
Transfer into DDW for 5 mins. 
10. Mount slides with aqueous mounting media and cover slides. 
11. Seal cover slides with Nail Varnish 
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B. FGF-2 ELISA Protocol For Cell Culture Supernate Samples (R & D Systems Inc, 
Minneapolis, MN). 
 
1. Aliquot samples as follows: 
a. 1 ml of DMEM 
b. DMEM + 20% FBS 
c. DMEM + 20% FBS + 10 ng/ml FGF-2 
d. DMEM + 20% FBS + 50 ng/ml FGF-2 
Each total volume of 1ml; giving four samples; allowing for triplication of 
samples 
2. Dilute the two FGF-2 groups by a factor of 100x with plain DMEM (no FBS, 
antibiotics or any growth factor added) to prevent an overflow reading.  
3. Next Steps are preformed using the Human FGF-2 Quantikine Kit (ref. DFB50 R&D 
Systems) 
4. FGF-2 Standard Preparation 
Reconstitute the FGF-2 Standard with 2 ml of the Calibrator Diluent RD5-14. This 
produces a stock solution of 640 pg/ml. Allow the standard to sit for 15 mins with 
gentle agitation prior to making diluents 
5. Standard Dilution Series 
Using eppendorfs pipette 500 µl of Calibrator Diluent RD5-14 into each tube. Use the 




6. Assay Procedure (Fig. 16)  
a. Remove excess microplate strips from the plate frame, return them to the foil 
pouch containing the desiccant pack, reseal. Make sure to allow for triplication 
of each sample in the wells. 
b. Add 100 µl of Assay Diluent (RD1-43) to each well.  
c. Add 100 µl of Standard or sample to each well. Cover with the adhesive strip 
provided and incubate for 2 hours at RT. Place the plate into the foil pouch and 
seal it. Record the sample triplication on plate layout sheet provided.   
d. Aspirate each well and wash, repeating the process twice for a total of three 
washes. Wash by filling each well with Wash Buffer (approx 400 µl per 
wash), using a Finnpipette (Fisherbrand). Tap the well plate, gently on the 
bench to obtain complete removal of wash buffer, after the last wash. Wash 
buffer remnants will cause dilution of the assay reagents to be used next, 
interfering with the reaction giving erroneous results.   
e. Add 200 µl of FGF-2 Conjugate to each well. Cover with an adhesive strip. 
Incubate for 2 hours at RT and place the plate into the foil pouch.   
f. Repeat the washing as in step d, being careful to wash correctly so as to 
remove the unbound antibody and wash buffer completely.   
g. In a dark room add 200 µl of Substrate Solution to each well. Incubate for 
approximately 30 mins at RT.  
h. Add 50 µl of Stop Solution to each well, observing a color change in each 
well. If the color change does not appear uniform gently tap the plate to ensure 
through mixing.  
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i. Determine the optical density of each well within 30 mins of step h, using a 
microplate reader set to 450 nm 
7. Re-calculate the concentration of growth factors in the medium by multiplying each 
sample reading from the microplate reader by a factor of 100, to allow for dilution 
(step 2). The standard preparation must be in pg/ml not ng/ml to prevent overflow, as 
pg/ml concentration is the standard which the microplate reader will use to compare to 
the triplicated samples.  
























Mix solution A and B. (e.g. 
2000 µL of sol. A + 2000 µL 
of sol. B – 20 wells).  
(Always prepare 200 or 400 
µL more.)   
Cover the plate with 
the adhesive strip 
and keep on the 









(3X 400 µL). 
Dry by gently 















C. VEGF ELISA Protocol for Cell Culture Supernate Samples (R & D Systems Inc, 
Minneapolis, MN) 
 
1. Aliquot samples as follows: 
a. 1 ml of DMEM 
b. DMEM + 20% FBS 
c. DMEM + 20% FBS + 10 ng/ml VEGF 
d. DMEM + 20% FBS + 50 ng/ml VEGF 
Each total volume of 1 ml; giving four samples; allowing for triplication of 
samples 
2. Dilute the two VEGF groups by a factor of 100x with plain DMEM (no FBS, 
antibiotics or any growth factor added) to prevent an overflow reading. 
3. Next Steps are preformed using the Human VEGF Quantikine ELISA Kit (ref. 
DVE00, R&D Systems, Minneapolis, MN) 
4. VEGF Standard Preparation 
Reconstitute the VEGF Standard with 1ml of the Calibrator Diluent RD5K. This 
produces a stock solution of 2000 pg/ml. Allow the standard to sit for 15 mins with 
gentle agitation prior to making dilutions 
5. Standard Dilution Series 
Using eppendorfs pipette 500 µl of Calibrator Diluent RD5K into each tube. Use the 
stock solution to produce a dilution series (Fig. 17). Mix each tube thoroughly before 
next transfer. Calibrator Diluent RD5K serves as the zero standard (0 pg/mL). 
6. Assay Procedure (Fig. 18)  
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e. Remove excess microplate strips from the plate frame, return them to the foil 
pouch containing the desiccant pack, reseal. Make sure to allow for triplication 
of each sample in the wells.  
f. Add 50 µl of Assay Diluent (RD1W) to each well 
g. Add 200 µl of Standard or sample to each well. Cover with the adhesive strip 
provided and incubate for 2 hours at RT. Place the plate into the foil pouch and 
seal it. Record the sample triplication on plate layout sheet provided.   
h. Aspirate each well and wash, repeating the process twice for a total of three 
washes. Wash by filling each well with Wash Buffer (approx 400 µl per 
wash), using a Finnpipette (Fisherbrand). Tap the well plate, gently on the 
bench to obtain complete removal of wash buffer, after the last wash. Wash 
buffer remnants will cause dilution of the assay reagents to be used next, 
interfering with the reaction giving erroneous results.   
i. Add 200 µl of VEGF Conjugate to each well. Cover with an adhesive strip. 
Incubate for 2 hours at RT and place the plate into the foil pouch.   
j. Repeat the washing as in step d, being careful to wash correctly so as to 
remove the unbound antibody and wash buffer completely.   
k. In a dark room add 200 µl of Substrate Solution to each well. Incubate for 
approximately 20 mins at RT.  
l. Add 50 µl of Stop Solution to each well, observing a color change in each 
well. If the color change does not appear uniform gently tap the plate to ensure 
thorough mixing.  
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m. Determine the optical density of each well within 30 mins of step h, using a 
microplate reader set to 450 nm 
7. Re-calculate the concentration of growth factors in the medium by multiplying each 
sample reading from the microplate reader by a factor of 100, to allow for dilution 
(step 2). The standard preparation must be in pg/ml not ng/ml to prevent overflow, as 
pg/ml concentration is the standard which the microplate reader will use to compare to 
the triplicated samples.  








































(3X 400 µL). 
Dry by gently hitting 
on the bench 
Cover the plate with 
the adhesive strip 
and keep on the 
bench or seal it in the 
silver pouch 
Mix solution A and B. (e.g. 
2000 µL of sol. A + 2000 µL 
of sol. B – 20 wells).  
Always prepare 200 or 400 
µL more.   
Figure 18. VEGF Elisa Assay Summary (R & D Systems). 
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D. Demineralization Protocol 
 
1. Following Fixation of the severed human dental pulps in 10% Neutral Buffered 
formalin (ref. SF100-4, Fisher Scientific) wash the tooth slices three times with PBS 
1x (ref. 10010 Gibco). 
 
2. Place four tooth slices (maximum) in a 50 ml BD FalconTM Tube (ref. 3521956 BD, 
Biosciences, Franklin Lakes, NJ.). 
 
3. Fill the tube with 40 ml of Decalcifier II (ref 00460 EDTA/HCl; Surgipath). The 
decalcifier is highly corrosive and is a strong acid. Take precautions to protect against 
splashes and spillages. Filling the tube with 40 ml leaves space for an air bubble 
which will assist with fluid flow over the tooth slices, during rotation. 
 
4. Seal the Falcon Tube/s and place them on a rotator (Reciprocating Shaker Model 
Number: 30153. Barnstead International, Dubuque, Iowa, IA) at RT to create fluid 
circulation over the tooth slices.  
 
5. 1 mm thick tooth slices should be exposed to the Decalcifier II for no more than 22-24 
hours. After this time damage to the pulp tissue may occur, this may impair 
immunohistochemcial staining.  
 
6. Remove the tooth slices from the Falcon Tube/s and wash with PBS 1x.  
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7. Trim the demineralized dentin from the periphery of the tooth slices with a razor blade 
(ref. 94-0451 Safety Razor Blade, Verona, VA), leaving approximately 1mm adjacent 
to the fixed pulp tissue. During trimming the level of demineralization can be 
assessed. In general 24 hours of demineralization is sufficient.  
 
8. Place the trimmed tooth slices in a Falcon tube containing 15-30 ml of 70% ETOH.  
 

















E. Acquiring TIFF images, Grid Application and Microvessel Quantification of Severed 
Human Pulps using Image Pro Plus 
 
Part I: Acquiring TIFF Images  
 
1. Place a single histology slide in the slide mount of the microscope (Eclipse E800, 
Nikon, Melville, NY).  
 
 
2. Open Image Pro Plus (version 5.1.2.59 for Windows XP. Media Cybernetics Inc, 
Silver Spring, MD). Click on Acquire in the drop down menu and scroll to Scan. 
 
3. This will open the Camera (Spot RT, Diagnostic Instruments Inc, Sterling Heights, 
MI) window. Click on the Live button (top left of the open window). This displays a 
live image of the histology slide at whatever power the objective lense of the 
microscope is set to. Images should be acquired on the Brightfield-Transmitted light 
setting, as seen in the Camera window (bottom). 
 
4. On Live image open window, click on the controls icon (bottom of the Live image 
window). Click on the drop down menu for Filter Color and scroll to the Clear setting 
from the current RGB setting. This changes the color setting of the live image, to 
clear. It is best to use this mode when selecting the correct fields after grid 
application. This prevents image blurring and allows Image Pro Plus to process the 
image in a faster fashion. The full chip selection box on the open window must be 
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selected. Before you acquire an image set the Filter Color to RGB.  
 
5. Click Snap in the open window. This acquires the image and it appears in another 
window. All pictures taken must be saved in TIFF and not as a JPEG file. TIFF offer 
better resolution, which is important when counting microvessels from images, 
obtained using the 200x objective. TIFFs should be converted to JPEG if they will be 
used in a manuscript or a publication.  
 
 
Part II: Grid Application 
 
1. Obtain an image as described above but with the 20x objective and save it as a TIFF. 
A Grid is then applied to the 20x TIFF image (of for example, the complete tooth 
slice). 
 
2. From the drop down menu, click Process and scroll to Create Mask.  On the open 
window, verify that the grid spacing parameters are set to 160.4 and 100.4. Select 
Lines in the Objects column and Orthogonal in the Layout column. These specific 
settings create lined grid boxes, which are the same size as the image obtained with 
the 200x microscope objective.  Specific fields are then selected after the grid is 
superimposed on the TIFF image.   
 
3. Click Apply, followed by Create Mask and then click OK.  From the drop down 
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menu, click Process and scroll to Image Overlay. Select the image, which the grid will 
be superimposed on from the Transparency drop down menu. Click Overlay in the 
open window.  
 
4. Move the grid which was over laid, on the source image. Once it is in the appropriate 
position click Merge. This merges the grid with the 20x TIFF image in the form of a 
grayscale picture. Save this image. This can be printed and fields are chosen at 
random using this printed image. 200x TIFFs are then obtained of these chosen fields, 
by moving the microscope stage and thus the histological slide to the correct grid 
location. Use the printed image as a guide (Fig. 7).  
 
Part III:  Microvessel Counting using Image Pros Plus Manual Tag 
 
1. Open a saved 200x TIFF that was obtained from a specific grid reference. 
 
2. From the drop down menu, click Measure and scroll to Manual Tag. Manual tagging 
allows individual microvessel counting and in doing so, a number is applied to each 
microvessel (red stained by Factor VIII Immunohistochemistry; APPENDIX). This 
prevents double counting of microvessels as could occur by manual counting.  
 
 
3. Click on Tag points in the open window. The Add New Points window opens. Click 
on a microvessel in the 200x TIFF image. This places a number next to the specific 
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microvessel and now a Total Count is recorded.   
 
4. Total counts from the 200x fields/tooth slice are input into an excel spreadsheet. Data 
is then input into SigmaStat for statistical analyses (MATERIALS and METHODS).  
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F. Preparation of Tooth Slices with No Severed Human Dental Pulp Tissue for Implantation 
into Severely Combined Immunodeficient Mice 
Vital, non-carious and non-restored human third molars from patients not older than 30 years 
of age were collected from the Oral Surgery Department of the University of Michigan 
School of Dentistry, Ann Arbor, Michigan. After extraction the teeth were immediately 
placed into sterile Transport Medium (High glucose DMEM (Sigma Chemical Co.) 
supplemented with 5 ml L-glutamine (Gibco) 200 mM, 5 ml of 10,000 units of penicillin and 
10 mg/ml streptomycin (Gibco) and 1 ml Amphotericin B (Sigma) 1.25 mg/l). 
The teeth were surface disinfected using a sterile gauze swab soaked in 70% ethanol solution. 
Excess soft tissue covering the root surface was removed by trimming with a sterile curette.   
 
Preparation of Specimens 
Teeth were fixed to a wooden block (3 cm x 3 cm x 1.5 cm) by self curing acrylic (Coldpac, 
tooth acrylic, Moltoid, Chicago, IL ref 44100) and these blocks were attached to an Isomet 
Low Speed (Model 650, South Bay Technology, Inc.) saw mount. The teeth were cut into 
sections of 1 mm thickness with a lapidary blade 303 Series (MK-303 Professional – Mk 
Diamond Products Inc.) and cooled with sterile PBS-1x-phosphate buffered saline (ref. 10010 
Gibco). The sterility of the saw was maintained by washing with 70% ethanol and sterile 
PBS. 
The pulp tissue was removed from each tooth slice with a sterile curette. Once the pulp was 
removed the pulpal-dentin junction was scrapped with the curette (kindly donated by the 
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Department of Periodontics and Oral Surgery, University of Michigan School of dentistry, 
Ann Arbor)  so as to completely remove any remaining pulp tissue.  
The above procedure was repeated until 12 tooth slices (six tooth slices with no pulp tissue 
per experiment) with no pulp tissue were deemed suitable for SCID mouse implantation.  
 
Storage of Tooth Slices Prior to Implantation 
The 12 slices were then placed into a 50 ml BD FalconTM Tube (ref  3521956 BD, 
Biosciences, Franklin Lakes, NJ.) containing 15ml of 70% ETOH. The ETOH storage 
disinfects the tooth slices prior to implantation.  
The day before implantation six tooth slices were removed from the 70% ETOH, in the 
laboratory fume hood and are washed three times in sterile PBS 1x (Gibco). Each slice is 
placed into a well of a 6 well plate, containing 5ml of PBS 1x. The well plate is sealed with 
parafilm (ref. 52858-000 Parafilm MTM.) and placed in a refrigerator.  
The day of the implantation surgery the tooth slices are removed from the refrigerator and 








G. IRB and UCCA Protocols 
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